Evidence map›Paper›PMID 28493984›Full record

ArticlePloS one2017

Nasal airway epithelial cell IL-6 and FKBP51 gene expression and steroid sensitivity in asthmatic children.

Michael Fayon, Aurelie Lacoste-Rodrigues, Pascal Barat, Jean-Christophe Helbling, Fabienne Nacka, Patrick Berger, Marie-Pierre Moisan, Jean-Benoit Corcuff

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04068389 (Study of the Permeability of Atmospheric Particles Placenta), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04068389 completednot on this map

Study of the Permeability of Atmospheric Particles Placenta (Fine and Ultrafine Particles): Analysis of Fetal Retention

TypeobservationalSponsorUniversity Hospital, BordeauxRan2009 to 2012Enrolled62ConditionsLung, Premature, Pollution, ExposureArmsPulmonary Tissue Collection
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Heterogeneity of Treatment Response to Asthma.Advances in experimental medicine and biology · 2023
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Michael FayonUniversité de Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Bordeaux, France.ORCID http://orcid.org/0000-0002-1238-2128
Aurelie Lacoste-RodriguesUniversité de Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Bordeaux, France.
Pascal BaratCHU de Bordeaux, Centre d'Investigation Clinique (CIC 1401), Bordeaux, France.
Jean-Christophe HelblingUniversité de Bordeaux, Nutrition and Integrative Neurobiology, Bordeaux, France.
Fabienne NackaCHU de Bordeaux, Centre d'Investigation Clinique (CIC 1401), Bordeaux, France.
Patrick BergerUniversité de Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Bordeaux, France.
Marie-Pierre MoisanUniversité de Bordeaux, Nutrition and Integrative Neurobiology, Bordeaux, France.
Jean-Benoit CorcuffUniversité de Bordeaux, Nutrition and Integrative Neurobiology, Bordeaux, France.
Université de Bordeaux · FRCentre Hospitalier Universitaire de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany asthmatic patients exhibit uncontrolled asthma despite high-dose inhaled corticosteroids (ICS). Airway epithelial cells (AEC) have distinct activation profiles that can influence ICS response.

objectivesA pilot study to identify gene expression markers of AEC dysfunction and markers of corticosteroid sensitivity in asthmatic and non-asthmatic control children, for comparison with published reports in adults.

methodsAEC were obtained by nasal brushings and primary submerged cultures, and incubated in control conditions or in the presence of 10 ng/ml TNFalpha, 10-8M dexamethasone, or both. RT-PCR-based expression of FKBP51 (a steroid hormone receptor signalling regulator), NF-kB, IL-6, LIF (an IL-6 family neurotrophic cytokine), serpinB2 (which inhibits plasminogen activation and promotes fibrin deposition) and porin (a marker of mitochondrial mass) were determined.

results6 patients without asthma (median age 11yr; min-max: 7-13), 8 with controlled asthma (11yr, 7-13; median daily fluticasone dose = 100 μg), and 4 with uncontrolled asthma (12yr, 7-14; 1000 μg fluticasone daily) were included. Baseline expression of LIF mRNA was significantly increased in uncontrolled vs controlled asthmatic children. TNFalpha significantly increased LIF expression in uncontrolled asthma. A similar trend was observed regarding IL-6. Dexamethasone significantly upregulated FKBP51 expression in all groups but the response was blunted in asthmatic children. No significant upregulation was identified regarding NF-kB, serpinB2 and porin.

conclusionLIF and FKBP51 expression in epithelial cells were the most interesting markers of AEC dysfunction/response to corticosteroid treatment.

Indexed as

AdolescentAdrenal Cortex HormonesAnti-Asthmatic AgentsAsthmaChildFemaleHumansInterleukin-6Leukemia Inhibitory FactorMaleNasal MucosaPilot ProjectsRNA, MessengerTacrolimus Binding Protein 5Tacrolimus Binding ProteinsAdrenal Cortex HormonesAnti-Asthmatic AgentsInterleukin-6Leukemia Inhibitory FactorLIF protein, humanRNA, MessengerTacrolimus Binding Protein 5Tacrolimus Binding Proteins

Identifiers

PMID28493984
PMCPMC5426685
OpenAlexW2612695631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.